tradingkey.logo

Maxlinear Inc <MXL.OQ> expected to post a loss of 13 cents a share - Earnings Preview

ReutersJan 27, 2025 9:09 PM
  • Maxlinear Inc MXL.OQ MXL.O is expected to show a fall in quarterly revenue when it reports results on January 29 for the period ending December 31 2024

  • The Carlsbad California-based company is expected to report a 28.3% decrease in revenue to $89.9 million from $125.35 million a year ago, according to the mean estimate from 10 analysts, based on LSEG data.The company's guidance on October 23 2024, for the period ended December 31, was for revenue between $80.00 million and $100.00 million.

  • ​LSEG's mean analyst estimate for Maxlinear Inc is for a loss of 13 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Maxlinear Inc is $22.00​, below​ its last closing price of $23.17. ​​​

The company's guidance on October 23 2024 for the period ended December 31 was for gross profit margin between USD57.5% and USD60.5%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.32

-0.32

-0.36

Missed

-11.3

Jun. 30 2024

-0.20

-0.19

-0.25

Missed

-28.6

Mar. 31 2024

-0.21

-0.22

-0.21

Beat

3.2​

Dec. 31 2023

0.01

0.01

0.01

Met

28.5

​​Sep. 30 2023

0.04

0.04

0.02

Missed

-45.9

Jun. 30 2023

0.33

0.33

0.34

Beat

1.8​

Mar. 31 2023

0.70

0.70

0.74

Beat

5.2

Dec. 31 2022

1.07

1.06

1.07

Beat

0.8

This summary was machine generated January 27 at 21:09 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI